We acknowledge that the experimental conditions involving different cytokines (IL-15 for NK cells and no cytokine for T cells) may have introduced variability such that IL-15 may contribute to some non-specific anti-tumor reactivity. The gene discussed is IL15; the disease is neoplasm.